Closure of Trading Window
Filed with BSE · · 1 page · English
Registered Address: 103, F-1, Leela Apartment, Shilpa Hou. Society, Saptagiri Nagar, Near Shanidham, Narendra Nagar, Nagpur, Maharashtra, India – 440015. Email: goldlinepharmaceuticalsltd@gmail.com Contact No.: +91 9561132666 Website: https://www.goldlinepharma.in/ Tel Phone: +91-712-2786666 Date: 27th May, 2026 Sub: Intimation of Closure of Trading Window. We wish to inform you that pursuant to S
Goldline Pharmaceutical Ltd. on 6ix
Later from Goldline Pharmaceutical
- Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 To Be Held On Tuesday, June 09, 2026.
- Goldline Pharmaceutical Ltd. Press Release Jun 02 2026
- Outcome Of Board Meeting Held Today, I.E., 09Th June, 2026
- Board Meeting Outcome for Outcome Of Board Meeting Held Today, I.E., 09Th June, 2026
- Announcement under Regulation 30 (LODR)-Change in Management
Follow Goldline Pharmaceutical into a list and get an email when it puts out news.
Follow Goldline Pharmaceutical